Changes of adiponectin and its receptors in rats following chronic renal failure

Renal Failure

Volumn 36, Issue 1, 2014, Pages 92-97

  Yu, Yan ^a   Bao, Bai Jun ^a   Fan, Ya Ping ^a   Shi, Lan ^a   Li, Shao Qing ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Adiponectin; Adiponectin receptor; Animal experiment; Changes; Chronic renal failure

Indexed keywords

ADENINE; ADIPONECTIN; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; CREATININE; DRINKING WATER; EOSIN; HEMATOXYLIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; REAL TIME POLYMERASE CHAIN REACTION; STAINING; UREA BLOOD LEVEL; URINALYSIS; URINARY EXCRETION;

ADIPONECTIN; ANIMALS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; RANDOM ALLOCATION; RATS; RECEPTORS, ADIPONECTIN; RNA, MESSENGER;

EID: 84889562368     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.830975     Document Type: Article

References (25)

1. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMPactivated protein kinase. Nat Med. 2002;8:1288-1295.
2. Santaniemi M, Kesaniem YA, Ukkola O. Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur J Endocrinol. 2006;155:745-750.
3. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7:947-953.
4. Kamimura MA, Canziani ME, Sanches FR, et al. Variations in adiponectin levels in patients with chronic kidney disease: a prospective study of 12 months. J Bras Nefrol. 2012;34(3): 259-265.
5. Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant. 2005;20:129-134.
6. Cui J, Panse S, Falkner B. The role of adiponectin in metabolic and vascular disease: a review. Clin Nephrol. 2011;75:26-33.
7. Shibata R, Ouchi N, Murohara T. Adiponectin and cardiovascular disease. Circ J. 2009;73:608-614.
8. Adamczak M, Chudek J, Wiecek A. Adiponectin in patients with chronic kidney disease. Semin Dial. 2009;22:391-395.
9. Zoccali C, Mallamaci F. Obesity, diabetes, adiponectin and the kidney: a podocyte affair. Nephrol Dial Transplant. 2008;23: 3767-3770.
10. Nakagawa N, Yao N, Hirayama T, et al. Potential impact of renin-angiotensin system inhibitors and calcium channel blockers on plasma high-molecular-weight adiponectin levels in hemodialysis patients. Hypertens Res. 2011;34:592-598.
11. Yokozawa T, Zheng PD, Oura H, Koizumi F. Animal model of adenine-induced chronic renal failure in rats. Nephron. 1986;44: 230-234.
12. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270:26746-26749.
13. Fan YP, Yu Y. Intervention of dyslipidemia in chronic kidney disease. Chinese J Nephrol. 2010;26:233-237.
14. Cammisotto PG, Bendayan M. Adiponectin stimulates phosphorylation of AMP-activated protein kinase alpha in renal glomeruli. J Mol Histol. 2008;39:579-584.
15. Zhou Z, Wu XY, Yao T, Gao P, Yu WL, Yang GM. Protective effect of adiponectin and its receptors in diabetic nephropathy rats. Chinese J Nephrol. 2010;26:702-707.
16. Fujita H, Morii T, Koshimura J, et al. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy. Endocr J. 2006;53:745-752.
17. Shen YY, Hughes JT, Charlesworth JA, Kelly JJ, Peake PW. Adiponectin is present in the urine in its native conformation and specifically reduces the secretion of MCP-1 by proximal tubular cells. Nephrology (Carlton). 2008;13:405-410.
18. Yaturu S, Reddy RD, Rains J, Jain SK. Plasma and urine levels of resistin and adiponectin in chronic kidney disease. Cytokine. 2007;37:1-5.
19. Malyszko J, Malyszko JS, Brzosko S, Wolczynski S, Mysliwiec M. Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients. J Clin Endocrinol Metab. 2004;89:4620-4627.
20. Stenvinkel P. Adiponectin in chronic kidney disease: a complex and context sensitive clinical situation. J Ren Nutr. 2011;21: 82-86.
21. Devarajan P. The use of targeted biomarkers for chronic kidney disease. Adv Chr Kid Dis. 2010;17:469-479.
22. Risch L, Saely C, Hoefle G, et al. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. Clin Chim Act. 2007;376:108-113.
23. Kawamoto R, Tabara Y, Kohara K, et al. Serum high molecular weight adiponectin is associated with mild renal dysfunction in Japanese adults. J Athero Thromb. 2010;17: 1141-1148.
24. Becker B, Kronenberg F, Kielstein JT, et al. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol. 2005;16:1091-1098.
25. Lin J, Hu FB, Curhan G. Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabet Care. 2007;30: 239-244.